Related Experiment Videos
AKT crystal structure and AKT-specific inhibitors
Chandra C Kumar1, Vincent Madison
1Department of Tumor Biology, Schering-Plough Research Institute, Kenilworth, NJ 07033, USA. chandra.kumar@spcorp.com
Oncogene
|November 17, 2005
Summary
Targeting AKT kinases, crucial for cancer cell survival, is a promising strategy for new drug discovery. This review details AKT inhibitors, structural insights, and challenges in developing effective cancer therapeutics.
Area of Science:
- Oncology
- Molecular Biology
- Drug Discovery
Background:
- AKT kinases play a critical role in tumor cell survival and proliferation.
- Overexpression and activation of AKT kinases are observed in numerous human cancers, making them attractive therapeutic targets.
Purpose of the Study:
- To review the rationale and recent progress in targeting AKT kinases for drug discovery.
- To summarize structural features, inhibitor development, and challenges in creating AKT-targeted therapeutics.
Main Methods:
- Analysis of crystal structures of AKT kinase in inactive and active states.
- Review of small molecule inhibitors targeting the ATP binding site, PH domain, and protein substrate binding site.
- Discussion of structure-based design, computer modeling, and allosteric inhibitor development.
Main Results:
- Various small molecule inhibitors targeting different sites of AKT kinase have been developed.
- Structural studies provide insights into AKT kinase's inactive and active conformations, aiding inhibitor design.
- Development of isoform-selective allosteric inhibitors shows promise.
Conclusions:
- Targeting AKT kinases remains a key strategy in cancer drug discovery.
- Challenges in developing selective and effective AKT inhibitors persist, requiring further research.
- Continued exploration of diverse inhibitor classes and design strategies is essential for therapeutic advancement.